TANYA CLIFFORD: Open Payments
NPI 1699853531 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,018 in 77 payments from 31 companies in 2025. Trend: 2023 $2,213 · 2024 $2,824 · 2025 $2,018
Food & beverage: $1,940Education: $78
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $325 |
| Daiichi Sankyo Inc. | 11 | $250 |
| Janssen Biotech, Inc. | 4 | $186 |
| GlaxoSmithKline, LLC. | 3 | $184 |
| PFIZER INC. | 7 | $148 |
| Novartis Pharmaceuticals Corporation | 4 | $102 |
| ARRAY BIOPHARMA INC | 4 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $82 |
| Eisai Inc. | 2 | $59 |
| ADC THERAPEUTICS AMERICA, INC. | 3 | $54 |
Products named: DATROWAY, ZEJULA, Enhertu, Nubeqa, DARZALEX, RYBREVANT, BRAFTOVI, JEMPERLI.
Industry payments across MD — which companies pay providers there.
